Borderline Personality Disorder: Updates in a Postpandemic World

Area of Science:

• Psychiatry
• Neuroscience
• Clinical Psychology

Background:

• Borderline personality disorder (BPD) understanding has advanced significantly in the past decade.
• BPD is now recognized as a distinct diagnosis, separate from comorbid conditions like mood and anxiety disorders.
• It is also viewed as a manifestation of general personality dysfunction, sharing traits with all personality disorders.

Purpose of the Study:

• To review the progress in understanding BPD over the last decade.
• To highlight neurobiological findings and their implications for treatment.
• To discuss the evolving landscape of BPD psychotherapies and clinical management.

Main Methods:

• Review of recent neuroimaging research.
• Analysis of advancements in understanding personality disorders.
• Synthesis of current evidence on psychotherapeutic and pharmacological treatments for BPD.

Main Results:

• Neuroimaging reveals shared frontolimbic dysfunction in BPD, alongside a distinct signature of hypersensitivity in interpersonal and emotional processing.
• Effective psychotherapies and clinical management strategies are conceptually based on this unique BPD signature.
• Medications are considered adjunctive, with some guidelines advising against their use; less invasive brain-based therapies show potential.

Conclusions:

• The treatment landscape is shifting towards briefer, less intensive generalist management formats, including shorter variants of dialectical behavior therapy and mentalization-based treatment.
• Earlier intervention and a focus on functional improvement are crucial for mitigating BPD-related disabilities and risks.
• Remote interventions offer a promising avenue for expanding access to care for individuals with BPD.